Clinical Research and Public HealthIn-Press PreviewAIDS/HIVEndocrinology
Open Access |
10.1172/jci.insight.195922
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Alba, D. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Abdellatif, A. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Choi, M. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Brown Mayfield, S. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Pham, T. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Berrios, D. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Rodriguez, A. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Ewing, M. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Figueroa, T. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Gonzalez-Vargas, J. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Zhang, N. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by
An, Z.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by Bu, D. in: PubMed | Google Scholar
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by
Deeks, S.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by
Scherer, P.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by
Hunt, P.
in:
PubMed
|
Google Scholar
|
1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
2University of California San Francisco Center for AIDS Research, San Francisco, United States of America
3Division of Endocrinology and Metabolism, UCSF, San Francisco, United States of America
4UCSF Diabetes Center, UCSF, San Francisco, United States of America
5Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America
6UCSF, San Francisco, United States of America
7Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medic, University of Texas Health Science Center at Houston, Houston, United States of America
8Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, United States of America
9Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital and UCSF, San Francisco, United States of America
Find articles by
Koliwad, S.
in:
PubMed
|
Google Scholar
|
Published June 30, 2026 - More info
BACKGROUND. Despite antiretroviral therapy (ART), people with HIV (PWH) are at heightened risk for insulin resistance (IR) and type 2 diabetes (T2D). Subcutaneous adipose tissue (SAT) fibrosis contributes to metabolic disease, but its role in IR among PWH is unknown. We investigated the relationship between SAT fibrosis and IR in PWH, along with transcriptional signatures to distinguish it from SAT fibrosis due to obesity.
METHODS. We analyzed body composition and SAT fibrosis (hydroxyproline) in 46 PWH and 74 people without HIV (PWoH), excluding individuals with T2D. We examined fibrosis-related gene transcription in the SAT using a targeted panel and measured plasma endotrophin, a marker of extracellular matrix (ECM) remodeling.
RESULTS. PWH had substantially more SAT fibrosis than PWoH, notably in non-obese individuals. Moreover, SAT fibrosis in these PWH was strongly associated with IR, independently of prior legacy ART or ongoing integrase strand inhibitor treatment. This SAT fibrosis was highlighted by a distinct transcriptional pattern marked by upregulation of COL14A1, key immune-related genes (e.g., CCL4, NLRP3), and pathways governing ECM remodeling and immune activation, as well as downregulation of thermogenic, lipid metabolic, and insulin signaling pathways. Plasma endotrophin levels were also elevated in PWH and correlated independently with SAT fibrosis.
CONCLUSION. SAT fibrosis was associated with IR independent of obesity in PWH and was mirrored by circulating endotrophin levels, offering a plausible noninvasive biomarker for early intervention. The distinct transcriptional signature of HIV-associated SAT fibrosis highlights candidate mechanisms that may underlie metabolic risk and offer therapeutic avenues in this population.